Drug General Information
Drug ID	D0Q8WG
Former ID	DIB006506
Drug Name	Tedalinab
Drug Type	Small molecular drug
Indication	Pain [ICD9: 338, 356.0, 356.8,780; ICD10:G64, G90.0, R52, G89]		Phase 1	[548356]
Company	Glenmark Pharmaceuticals Ltd
Structure		Download 2D MOL 3D MOL
Formula	C19H21F2N3O
PubChem Compound ID	67029278
Target and Pathway
Target(s)	Cannabinoid receptor 2	Target Info	Agonist	[551201]
KEGG Pathway	Neuroactive ligand-receptor interaction
Reactome	Class A/1 (Rhodopsin-like receptors)
	G alpha (i) signalling events
WikiPathways	GPCRs, Class A Rhodopsin-like
	Small Ligand GPCRs
	GPCR ligand binding
	GPCR downstream signaling
References
Ref 548356	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800024918)
Ref 551201	Cannabinoid CB2 receptor (CNR2). SciBX 3(46); doi:10.1038/scibx.2010.1384. Dec. 2 2010

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.